Management of recurrent hepatitis C after liver transplantation: a concise review

UMMS Affiliation

Department of Medicine, Division of Gastroenterology

Publication Date


Document Type



Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Transplantation; Prognosis; RNA, Viral; Recurrence; Ribavirin


Gastroenterology | Hepatology


Recurrent hepatitis C infection and subsequent graft failure are increasingly recognized problems after orthotopic liver transplantation. Although many prospective therapeutic, controlled trials in primary hepatitis C disease have been reported, large-scale studies are yet to be performed in patients with posttransplant recurrent hepatitis C after liver transplantation. In this review, we summarize the current literature on the therapeutic approaches for recurrent hepatitis C and discuss the results of published studies on therapy with ribavirin or interferon (IFN) alone and on combination therapy with IFN plus ribavirin. Further, we discuss results of prophylactic approaches to the problem of recurrent hepatitis C after transplant. Finally, we discuss additional aspects of anti-hepatitis C virus therapy after liver transplantation.

Rights and Permissions

Citation: Am J Gastroenterol. 2000 Sep;95(9):2164-70. Link to article on publisher's site

Journal/Book/Conference Title

The American journal of gastroenterology

Related Resources

Link to Article in PubMed

PubMed ID